医学
分子成像
食品药品监督管理局
肺癌
放射科
医学物理学
病理
药理学
生物技术
生物
体内
作者
Lye-Yeng Wong,Natalie S. Lui
标识
DOI:10.1016/j.thorsurg.2023.04.013
摘要
Intraoperative molecular imaging innovations have been propelled by the development of fluorescent contrast agents that specifically target tumor tissues and advanced camera systems that can detect the specified fluorescence. The most promising agent to date is OTL38, a targeted and near-infrared agent that was recently approved by the Food and Drug Administration for intraoperative imaging for lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI